This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Will Church & Dwight's Innovation & Global Expansion Fuel Growth?
by Zacks Equity Research
CHD boosts growth with brand innovation, strategic acquisitions and expanding global reach across consumer categories.
GO vs. CHD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GO vs. CHD: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Grocery Outlet
by Zacks Equity Research
Consumer staples leaders are navigating rising costs and shifting consumer behavior while innovating to sustain growth.
4 Consumer Product Stocks Showing Resilience Amid Market Headwinds
by Zacks Equity Research
Despite rising costs and shifting consumer trends, PG, CHD, OLLI and GO are demonstrating resilience by implementing strategic measures to sustain growth.
Zacks Investment Ideas feature highlights: Church & Dwight, Eli Lilly and Viatris
by Zacks Equity Research
CEOs at Church & Dwight, Eli Lilly, and Viatris are buying shares after stock pullbacks, signaling insider confidence.
Insider Watch: 3 CEOs Buying the Dip
by Derek Lewis
Large-cap stocks CHD, LLY, and VTRS have seen their respective CEOs make purchases over the last month. What do they see?
Procter & Gamble's Innovation Playbook: Working or Wearing Thin?
by Zacks Equity Research
PG leans on bold product launches like Tide evo and Swiffer PowerMop, but questions remain on whether innovation can keep fueling growth.
GO or CHD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GO vs. CHD: Which Stock Is the Better Value Option?
Top Research Reports for Amazon.com, Salesforce & Abbott
by Mark Vickery
Amazon posts strong Q2 gains across AWS, Prime and ads, but weak Q3 income guidance and AI costs drag shares lower.
Implied Volatility Surging for Church & Dwight Stock Options
by Zacks Equity Research
Investors need to pay close attention to CHD stock based on the movements in the options market lately.
Will Slowing Global Demand Dent PG's Emerging Market Strategy?
by Zacks Equity Research
Procter & Gamble's emerging market strength in Latin America and India shows resilience despite global demand concerns.
Will Colgate's Innovation Drive Market Share Gains in 2025?
by Zacks Equity Research
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
by Zacks Equity Research
Procter & Gamble faces slowing category growth as inflation and tariffs challenge its long-running price hike strategy.
GO vs. CHD: Which Stock Is the Better Value Option?
by Zacks Equity Research
GO vs. CHD: Which Stock Is the Better Value Option?
Procter & Gamble's Margins Stay Firm: Is Premiumization Paying Off?
by Zacks Equity Research
PG expands core margins and grows EPS despite volatility, signaling the strength of its premiumization strategy.
Church & Dwight Q2 Earnings Beat Estimates, Volumes Fuel Organic Sales
by Zacks Equity Research
CHD posts earnings beat in second-quarter 2025. Net sales dip 0.3% year over year on negative pricing and mix.
Company News for Aug 4, 2025
by Zacks Equity Research
Companies in The News Are: ENB,D,KMB,CHD
Compared to Estimates, Church & Dwight (CHD) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Church & Dwight (CHD) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Church & Dwight (CHD) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of +10.59% and +1.76%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Newell to Report Q2 Earnings: Does a Surprise Await Investors?
by Zacks Equity Research
While inflation, weak demand and currency headwinds are expected to have hurt NWL's Q2 performance, restructuring might have softened the blow.
AB InBev Q2 Earnings Around the Corner: Will It Surpass Estimates?
by Zacks Equity Research
BUD's Q2 earnings are anticipated to rise 4.4% y/y as premiumization, pricing and digital gains offset macro and cost pressures.
Colgate Q2 Earnings: Do Productivity Initiatives Suggest a Beat?
by Zacks Equity Research
CL's Q2 results are likely to reflect benefits from pricing, innovation and gross margin gains amid inflation and foreign exchange headwinds.
Curious about Church & Dwight (CHD) Q2 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Church & Dwight (CHD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Clorox Pre-Q4 Earnings Send Mixed Signals: Time to Accumulate Shares?
by Zacks Equity Research
CLX's Q4 performance is likely to have benefited from margin strength and innovation, but macro headwinds and rising costs keep investors cautious.
Church & Dwight (CHD) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.